Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | methionine aminopeptidase | 0.0256 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.2065 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.2065 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.2065 | 1 | 1 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.2065 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0349 | 0.051 | 0.051 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.2065 | 1 | 1 |
Treponema pallidum | aminopeptidase P | 0.0256 | 0 | 0.5 |
Giardia lamblia | Methionine aminopeptidase | 0.2065 | 1 | 1 |
Leishmania major | methionine aminopeptidase 2, putative | 0.2065 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytoplasmic peptidase PepQ | 0.0256 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0256 | 0 | 0.5 |
Mycobacterium ulcerans | cytoplasmic peptidase PepQ | 0.0256 | 0 | 0.5 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.2065 | 1 | 1 |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.2065 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.2065 | 1 | 1 |
Mycobacterium ulcerans | dipeptidase PepE | 0.0256 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0256 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0256 | 0 | 0.5 |
Mycobacterium leprae | Probable cytoplasmic peptidase PepQ | 0.0256 | 0 | 0.5 |
Mycobacterium tuberculosis | Dipeptidase PepE | 0.0256 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.2065 | 1 | 1 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0256 | 0 | 0.5 |
Chlamydia trachomatis | aminopeptidase P | 0.0256 | 0 | 0.5 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.2065 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0256 | 0 | 0.5 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.2065 | 1 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0256 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.2065 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.2065 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | Xaa-Pro aminopeptidase | 0.0256 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0256 | 0 | 0.5 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.2065 | 1 | 1 |
Mycobacterium ulcerans | aminopeptidase | 0.0256 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0256 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.2065 | 1 | 1 |
Mycobacterium ulcerans | dipeptidase | 0.0256 | 0 | 0.5 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.2065 | 1 | 1 |
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.2065 | 1 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0349 | 0.051 | 0.051 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | 0 | Hydrolysis half life in CEM cell extracts at pH 6.9 | ChEMBL. | 17335187 |
Activity (ADMET) | 0 | Hydrolysis half life in RPMI-1650/FCS medium at pH 7.6 | ChEMBL. | 17335187 |
Activity (ADMET) | 0 | Hydrolysis half life in human serum at pH 6.8 | ChEMBL. | 17335187 |
EC50 (functional) | = 0.15 uM | Antiviral activity against HIV2 ROD in CEM/0 cells | ChEMBL. | 17335187 |
EC50 (functional) | = 0.41 uM | Antiviral activity against HIV1 in CEM/0 cells | ChEMBL. | 17335187 |
EC50 (functional) | = 5 uM | Antiviral activity against HIV2 ROD in CEM/TK- cells | ChEMBL. | 17335187 |
t1/2 | = 0.18 hr | Chemical stability in phosphate buffer at pH 7.3 | ChEMBL. | 17335187 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.